If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 562.00
Bid: 560.00
Ask: 568.00
Change: 12.00 (2.18%)
Spread: 8.00 (1.429%)
Open: 560.00
High: 562.00
Low: 550.00
Prev. Close: 550.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

7 Feb 2006 07:02

Gooch & Housego PLC07 February 2006 For Immediate Release 7 February 2006 Gooch & Housego PLC ACQUISITION OF CHROMODYNAMICS, INC. Gooch & Housego, the specialist manufacturer of advanced optoelectroniccomponents, materials, instruments and systems, is pleased to announce that ithas acquired ChromoDynamics, Inc. (CDI). Based in the USA, CDI is a developer ofhyperspectral imaging systems. Designed initially for use in conjunction withhigh-end research microscopes, the products are targeted at biomedical research,drug development and medical diagnostics. Future products will address a broadrange of applications including remote sensing and semiconductor inspectionsystems. CDI was founded in 1997 to transfer technology developed at Carnegie MellonUniversity ("CMU"), Pittsburgh, Pennsylvania, into the commercial realm, andbenefited from grants from the National Institutes of Health (NIH) and otherfunding bodies. CDI licenses key patents from CMU (exclusive to its targetmarkets) and has also developed its own intellectual property. Biomedicalimaging systems based on this technology have the potential to improve detectionof cancer and aid in drug development. Three first generation products have beensold to leading biomedical research and pharmaceutical organisations, and afourth to a manufacturer of semiconductor inspection equipment. CDI is now ready to commercialise the technology and make the transition fromresearch and development to production. Manufacturing resources and expertisewithin Gooch & Housego in acousto-optic tuneable filters (the key activecomponent in the system), spectroscopic instrumentation and electronics willenable CDI to achieve the scale necessary to address the market opportunity.Initial sales are expected in the 2007 financial year. The current sole employeeand co-founder will remain with CDI as Vice President of R&D and will providethe foundation for the new team. The consideration for the acquisition is $1,180,000 payable in cash oncompletion. During the year to 30 June 2005, CDI had an income of $229k and made a loss of$78,000. As at 31 May 2005, CDI had net assets of $26,000. Contacts: Gareth Jones, Chairman and Chief Executive Officer, 01460 52271 Tim Thompson, Buchanan Communication Ltd, 020 7466 5000 Andrew Edwards, Oriel Securities Limited, 020 7710 7600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Apr 20247:00 amRNSHalf Year Trading Update
18th Mar 20242:36 pmRNSDivestment of EM4
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20243:26 pmRNSNotification of Major Holdings
22nd Feb 20244:07 pmRNSNotification of Major Holdings
21st Feb 202412:31 pmRNSResult of AGM
21st Feb 202410:28 amRNSDirector/PDMR Shareholding
21st Feb 20249:43 amRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSAGM Trading Update
12th Jan 20247:00 amRNSAnnual Report and Notice of AGM
10th Jan 20247:00 amRNSGrant of LTIP Awards
9th Jan 202411:53 amRNSNotification of Major Holdings
8th Jan 20243:57 pmRNSNotification of Major Holdings
4th Jan 20243:20 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSResults for the year ended 30 September 2023
8th Nov 20237:00 amRNSNotification of Full Year Results
23rd Oct 20232:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSFull Year Trading Update
2nd Oct 20232:44 pmRNSHolding(s) in Company
9th Aug 20236:15 pmRNSDirector/PDMR Shareholding
31st Jul 20238:22 amRNSHolding(s) in Company
21st Jul 202311:58 amRNSCompletion of Acquisition and Issue of Equity
19th Jul 20237:00 amRNSAcquisition of Artemis Optical
23rd Jun 20234:11 pmRNSHolding(s) in Company
21st Jun 202310:26 amRNSDirector/PDMR Shareholding
20th Jun 20236:00 pmRNSAcquisition of GS Optics
6th Jun 20237:00 amRNSInterim Results
23rd May 20237:00 amRNSNotification of Half Year Results
3rd May 20238:56 amRNSIssue of Equity
4th Apr 20237:00 amRNSHalf Year Trading Update
30th Mar 20239:33 amRNSHolding(s) in Company
15th Mar 202312:00 pmRNSAppointment of Non-Executive Director
3rd Mar 20234:37 pmRNSHolding(s) in Company
2nd Mar 20231:10 pmRNSHolding(s) in Company
1st Mar 20239:44 amRNSHolding(s) in Company
22nd Feb 20231:50 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Trading Update
8th Feb 202312:59 pmRNSHolding(s) in Company
9th Jan 202311:44 amRNSGrant of LTIP Awards
21st Dec 202210:02 amRNSPosting of Annual Report and Notice of AGM
20th Dec 202212:30 pmRNSDirector/PDMR Shareholding
6th Dec 20224:26 pmRNSDirector/PDMR Shareholding
6th Dec 20229:38 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSResults for the year ended 30 September 2022
25th Nov 20223:17 pmRNSHolding(s) in Company
23rd Nov 20224:27 pmRNSHolding(s) in Company
18th Nov 20222:20 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSNotification of Full Year Results
27th Oct 202212:56 pmRNSHolding(s) in Company
18th Oct 20222:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.